Hemophilia A Research Program (HARP) Education/ LinkedIn
Jul 22, 2026, 09:46
Clinical Trial Recruitment for the HARP Mother–Baby Study – HARP
Hemophilia A Research Program (HARP) Education shared a post on LinkedIn:
“The HARP mother-baby study in hemophilia is recruiting! Please help us get the word out!
Interested pregnant moms can go to HARP.
Providers can directly refer at: [email protected]
Flyers can also be downloaded at HARP Resources.
Hemophilia A Research Program (HARP) is looking to reach pregnant mothers anywhere in the U.S. Eligible moms have a genotype that causes hemophilia A (sometimes known as ‘carriers’) and a baby potentially at-risk for severe hemophilia A.
HARP is studying hemophilia bleeding risk in pregnancy and the causes of inhibitor formation in early childhood. To learn more visit HARP and Clinical Trials.”

Stay updated with Hemostasis Today.
-
Nov 15, 2026, 23:44Pablo César Spada: Prevention of Venous Thromboembolism After Total Hip or Knee Replacement
-
Nov 15, 2026, 23:30Eshal Amir: Factor XI Inhibitors in AFib and Aortic Mortality Trends
-
Nov 15, 2026, 23:19Hamza Bashir: Adding Endovascular Therapy to Anticoagulation Cuts Moderate-to-Severe PTS in Half
-
Nov 15, 2026, 23:06Lanre Tunji-Ajayi: 2 Days of Deliberative Dialogue Hosted by the Network of Rare Blood Disorder Organizations
-
Nov 15, 2026, 23:00Fanny Delettre: Looking Back at Volunteer Blood Donor Friends Day
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines